Literature DB >> 20663981

Chemoprevention of head and neck cancer with green tea polyphenols.

Joseph W Kim1, A R M Ruhul Amin, Dong M Shin.   

Abstract

Recently, squamous cell carcinoma of the head and neck chemoprevention research has made major advances with novel clinical trial designs suited for the purpose, use of biomarkers to identify high-risk patients, and the emergence of numerous molecularly targeted agents and natural dietary compounds. Among many natural compounds, green tea polyphenols, particularly (-)-epigallocatechin-3-gallate (EGCG), possess remarkable potential as chemopreventive agents. EGCG modulates several key molecular signaling pathways at multiple levels and has synergistic or additive effects when combined with many other natural or synthetic compounds. This review will provide an update of the potential of green tea polyphenols, particularly EGCG, for the chemoprevention of squamous cell carcinoma of the head and neck. 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663981      PMCID: PMC2917478          DOI: 10.1158/1940-6207.CAPR-09-0131

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  91 in total

1.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins.

Authors:  M Nomura; W Ma; N Chen; A M Bode; Z Dong
Journal:  Carcinogenesis       Date:  2000-10       Impact factor: 4.944

2.  Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells.

Authors:  Nahid S Waleh; Wan-Ru Chao; Ahlem Bensari; Nurulain T Zaveri
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

Review 3.  Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin.

Authors:  J K Lin; Y C Chen; Y T Huang; S Y Lin-Shiau
Journal:  J Cell Biochem Suppl       Date:  1997

4.  Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

Authors:  Masood A Shammas; Paola Neri; Hemanta Koley; Ramesh B Batchu; Robert C Bertheau; Vidit Munshi; Rao Prabhala; Mariateresa Fulciniti; Yu Tzu Tai; Steven P Treon; Raj K Goyal; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

Review 5.  Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

Authors:  Gary J Kelloff; Scott M Lippman; Andrew J Dannenberg; Caroline C Sigman; Homer L Pearce; Brian J Reid; Eva Szabo; V Craig Jordan; Margaret R Spitz; Gordon B Mills; Vali A Papadimitrakopoulou; Reuben Lotan; Bharat B Aggarwal; Robert S Bresalier; Jeri Kim; Banu Arun; Karen H Lu; Melanie E Thomas; Helen E Rhodes; Molly A Brewer; Michele Follen; Dong M Shin; Howard L Parnes; Jill M Siegfried; Alison A Evans; William J Blot; Wong-Ho Chow; Patricia L Blount; Carlo C Maley; Kenneth K Wang; Stephen Lam; J Jack Lee; Steven M Dubinett; Paul F Engstrom; Frank L Meyskens; Joyce O'Shaughnessy; Ernest T Hawk; Bernard Levin; William G Nelson; Waun Ki Hong
Journal:  Clin Cancer Res       Date:  2006-06-15       Impact factor: 12.531

6.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors:  Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.

Authors:  Masahito Shimizu; Yasushi Fukutomi; Mitsuo Ninomiya; Kazuo Nagura; Tomohiro Kato; Hiroshi Araki; Masami Suganuma; Hirota Fujiki; Hisataka Moriwaki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

8.  Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate.

Authors:  Thomas Neuhaus; Stefan Pabst; Sebastian Stier; Artur-Aron Weber; Karsten Schrör; Agapios Sachinidis; Hans Vetter; Yon D Ko
Journal:  Eur J Pharmacol       Date:  2004-01-12       Impact factor: 4.432

9.  Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.

Authors:  Kedar Hastak; Sanjay Gupta; Nihal Ahmad; Mukesh K Agarwal; Munna L Agarwal; Hasan Mukhtar
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

10.  The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.

Authors:  Seiji Adachi; Tomokazu Nagao; Helgi I Ingolfsson; Frederick R Maxfield; Olaf S Andersen; Levy Kopelovich; I Bernard Weinstein
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

View more
  32 in total

Review 1.  Dietary epigenetics in cancer and aging.

Authors:  Trygve O Tollefsbol
Journal:  Cancer Treat Res       Date:  2014

2.  Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

Authors:  Laura Schramm
Journal:  J Carcinog Mutagen       Date:  2013-05-20

3.  Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.

Authors:  Rebecca J Leeman-Neill; Raja R Seethala; Shivendra V Singh; Maria L Freilino; Joseph S Bednash; Sufi M Thomas; Mary C Panahandeh; William E Gooding; Sonali C Joyce; Mark W Lingen; Daniel B Neill; Jennifer R Grandis
Journal:  Cancer Prev Res (Phila)       Date:  2010-12-16

4.  Alcohol and tea consumption in relation to the risk of nasopharyngeal carcinoma in Guangdong, China.

Authors:  Hong-Lian Ruan; Feng-Hua Xu; Wen-Sheng Liu; Qi-Sheng Feng; Li-Zhen Chen; Yi-Xin Zeng; Wei-Hua Jia
Journal:  Front Med China       Date:  2010-11-25

5.  (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.

Authors:  Sufang Liu; Hongde Li; Min Tang; Ya Cao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

6.  Radiation induced a supra-additive cytotoxic effect in head and neck carcinoma cell lines when combined with plant extracts from Brazilian Cerrado biome.

Authors:  Silvia T Elias; Gabriel A Borges; Danilo A Amorim; Daniela F Rêgo; Luiz A Simeoni; Dâmaris Silveira; Yris Maria Fonseca-Bazzo; José E Paula; Christopher William Fagg; Ivelone M C Barros; Wenzel C Abreu; Décio S Pinto-Júnior; Pérola O Magalhães; Francisco A R Neves; Adriana Lofrano-Porto; Eliete N S Guerra
Journal:  Clin Oral Investig       Date:  2014-08-07       Impact factor: 3.573

Review 7.  Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition.

Authors:  Sharmila Shankar; Dhruv Kumar; Rakesh K Srivastava
Journal:  Pharmacol Ther       Date:  2012-11-16       Impact factor: 12.310

Review 8.  Oral premalignancy: the roles of early detection and chemoprevention.

Authors:  Jean-Philippe Foy; Chloé Bertolus; William N William; Pierre Saintigny
Journal:  Otolaryngol Clin North Am       Date:  2013-05-25       Impact factor: 3.346

Review 9.  A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.

Authors:  Kyle Crooker; Rana Aliani; Megha Ananth; Levi Arnold; Shrikant Anant; Sufi Mary Thomas
Journal:  Cancer Prev Res (Phila)       Date:  2018-03-30

Review 10.  Glutamine at focus: versatile roles in cancer.

Authors:  Humberto De Vitto; Juan Pérez-Valencia; James A Radosevich
Journal:  Tumour Biol       Date:  2015-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.